ATE157003T1 - Verwendung von l-carnitin- und acyl-l- cernitinestern mit hydroxysäuren zur herstellung pharmazeutischer zusammensetzungen zur behandlung der dermatosen - Google Patents

Verwendung von l-carnitin- und acyl-l- cernitinestern mit hydroxysäuren zur herstellung pharmazeutischer zusammensetzungen zur behandlung der dermatosen

Info

Publication number
ATE157003T1
ATE157003T1 AT94108921T AT94108921T ATE157003T1 AT E157003 T1 ATE157003 T1 AT E157003T1 AT 94108921 T AT94108921 T AT 94108921T AT 94108921 T AT94108921 T AT 94108921T AT E157003 T1 ATE157003 T1 AT E157003T1
Authority
AT
Austria
Prior art keywords
carnitine
acyl
esters
pharmaceutical compositions
dermatoses
Prior art date
Application number
AT94108921T
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Application granted granted Critical
Publication of ATE157003T1 publication Critical patent/ATE157003T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT94108921T 1993-06-22 1994-06-10 Verwendung von l-carnitin- und acyl-l- cernitinestern mit hydroxysäuren zur herstellung pharmazeutischer zusammensetzungen zur behandlung der dermatosen ATE157003T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930399A IT1261984B (it) 1993-06-22 1993-06-22 Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (1)

Publication Number Publication Date
ATE157003T1 true ATE157003T1 (de) 1997-09-15

Family

ID=11401814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94108921T ATE157003T1 (de) 1993-06-22 1994-06-10 Verwendung von l-carnitin- und acyl-l- cernitinestern mit hydroxysäuren zur herstellung pharmazeutischer zusammensetzungen zur behandlung der dermatosen

Country Status (12)

Country Link
US (1) US5627212A (de)
EP (1) EP0631779B1 (de)
JP (1) JPH0710820A (de)
KR (1) KR950000142A (de)
AT (1) ATE157003T1 (de)
CA (1) CA2125238A1 (de)
DE (1) DE69405054T2 (de)
DK (1) DK0631779T3 (de)
ES (1) ES2107707T3 (de)
GR (1) GR3024866T3 (de)
IT (1) IT1261984B (de)
ZA (1) ZA944413B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US6630442B1 (en) * 1997-01-10 2003-10-07 Theodore Hersh Reparatives for chemosurgery and laser (thermal) therapy
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
DE19806889A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Verwendung von Acyl-Carnitin
DK0951909T4 (da) 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
FI111686B (fi) * 2000-04-20 2003-09-15 Simo Rasi Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US20050100519A1 (en) * 2003-03-28 2005-05-12 Lonza Inc. Topical L-carnitine compositions
CA2718276A1 (en) * 2008-03-13 2009-09-17 Perkinelmer Las, Inc. Enzymatic substrates for multiple detection systems
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
US20140274798A1 (en) 2013-03-15 2014-09-18 University Of Washington Through Its Center For Commercialization Compounds and methods relating to lysosomal storage disorders
CN116568292A (zh) * 2020-11-05 2023-08-08 莱托生物股份有限公司 用于治疗皮肤病症的新组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51148042A (en) * 1975-06-14 1976-12-18 Kanebo Ltd Skin toiletry
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
FR2654619B1 (fr) * 1989-11-23 1992-01-31 Sederma Sa Utilisation en cosmetique de composes destines a optimiser la penetration des principes actifs.
FR2654618B1 (fr) * 1989-11-23 1994-04-29 Sederma Sa Utilisation en cosmetique de principes actifs destines a reguler la multiplication cellulaire.
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.

Also Published As

Publication number Publication date
ITRM930399A0 (it) 1993-06-22
ZA944413B (en) 1995-02-15
US5627212A (en) 1997-05-06
EP0631779B1 (de) 1997-08-20
JPH0710820A (ja) 1995-01-13
DE69405054T2 (de) 1997-12-18
DK0631779T3 (da) 1997-09-15
CA2125238A1 (en) 1994-12-23
KR950000142A (ko) 1995-01-03
DE69405054D1 (de) 1997-09-25
ES2107707T3 (es) 1997-12-01
EP0631779A1 (de) 1995-01-04
ITRM930399A1 (it) 1994-12-22
IT1261984B (it) 1996-06-11
GR3024866T3 (en) 1998-01-30

Similar Documents

Publication Publication Date Title
DE69405054D1 (de) Verwendung von L-carnitin- und Acyl-L-cernitinestern mit Hydroxysäuren zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung der Dermatosen
ATE177947T1 (de) Verwendung von l-carnitin-o-estern zur behandlung der dermatosen
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE69403610D1 (de) Verfahren zur Herstellung von Ameisensäure und ihren Derivaten
TR200102170T2 (tr) Psikiyatrik ve nörolojik bozukluklar için yüksek ölçüde saflaştırılmış etil EPA ve diğer EPA türevleri.
EP0801565A4 (de) Verfahren und mittel zur topischen anwendung von tocotrienol auf die haut
BR9400774A (pt) Processo para produção de éster láctico e ácido láctico
ATE132040T1 (de) Verwendung von phospholipiden zur herstellung eines topischen arzneimittels zur beinflussung des serumcholesterinspiegels
ATE138639T1 (de) L-carnitin- und alkanoyl-l-carnitin-ester mit glykolsäure oder ihre ester und diese enthaltende pharmazeutische zusammensetzungen zur behandlung von dermatosen
DE69029100D1 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
DE69415081D1 (de) Verwendung von L-Carnitin-O-Estern mit aromatischen Säuren zur Behandlung der Dermatosen
DE69219602D1 (de) Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel
DE69501105D1 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE3483378D1 (de) Verfahren zur kontinuierlichen enzymatischen herstellung von gluconsaeure oder ihren derivaten und sorbit und/oder mannit.
PT90427A (pt) Processo para a preparacao de cloreto ferrico a partir de cloreto ferroso
MX169500B (es) Producion de sabor
KR910021363A (ko) 락트산 아실화물, 그의 염, 그의 제조 방법 및 이들을 함유하는 조성물
DE69503724D1 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE69428008D1 (de) Herstellungsverfahren von 2,5-Diarylamino-3,6-dihydroterephthalsäuredialkylester sowie die Herstellung von Chinacridonen aus diesen Estern als Zwischenstufen
DE69507822D1 (de) Herstellung der carbonsäuren oder ihrer ester durch carbonylierung in gegenwart von iridium
ATE161718T1 (de) Verwendung von l-carnitine oder acyl-l-carnitinen und valproat zur behandlung von anfallserkrankungen
DE69713596D1 (de) Antipsoriatische zusammensetzungen enthaltend einen extrakt von asphodelus, verfahren zur herstellung und verwendung
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
DE59504636D1 (de) Verfaharen zur herstellung von carboxy-arensulfonsäuren und deren carbonsäurederivaten
MX9300121A (es) Hidrolisis continua de acetato de celulosa.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee